Effects of L-dopa priming on cortical high beta and high gamma oscillatory activity in a rodent model of Parkinson's disease

Neurobiology of Disease

Volumn 86, Issue , 2016, Pages 1-15

  Dupre, Kristin B ^a   Cruz, Ana V ^a   McCoy, Alex J ^a   Delaville, Claire ^a   Gerber, Colin M ^a   Eyring, Katherine W ^a   Walters, Judith R ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Abnormal involuntary movements; Beta; Dopamine; Dyskinesia; Gamma; L dopa; Local field potential; Motor cortex; Oscillations; Parkinson's disease

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; BENSERAZIDE; DOPAMINE 1 RECEPTOR; LEVODOPA; LEVODOPA METHYL ESTER; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; QUINPIROLE; SEROTONIN 1A AGONIST; BENZAZEPINE DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT; OXIDOPAMINE; SEROTONIN AGONIST; SK&F 81297;

ACTION POTENTIAL DURATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA RHYTHM; BRAIN ELECTROPHYSIOLOGY; CELL SELECTION; CONTROLLED STUDY; DYSKINESIA; ELECTRODE; EXPERIMENTAL TEST; GAMMA RHYTHM; HISTOPATHOLOGY; INVOLUNTARY MOVEMENT; MALE; MOTOR CORTEX; NONHUMAN; OSCILLATION; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; RAT; STEPPING TEST; TREADMILL EXERCISE; WAVEFORM; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; MOTOR ACTIVITY; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BENZAZEPINES; DISEASE MODELS, ANIMAL; DOPAMINE AGONISTS; DYSKINESIA, DRUG-INDUCED; GAMMA RHYTHM; LEVODOPA; MALE; MOTOR ACTIVITY; MOTOR CORTEX; NEURONS; OXIDOPAMINE; PARKINSONIAN DISORDERS; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN RECEPTOR AGONISTS;

EID: 84948844686     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2015.11.009     Document Type: Article

References (80)

1. Alegre M., Alonso-Frech F., Rodriguez-Oroz M.C., et al. Movement-related changes in oscillatory activity in the human subthalamic nucleus: ipsilateral vs. contralateral movements. Eur. J. Neurosci. 2005, 22(9):2315-2324.
2. Alegre M., Lopez-Azcarate J., Alonso-Frech F., et al. Subthalamic activity during diphasic dyskinesias in Parkinson's disease. Mov. Disord. 2012, 27(9):1178-1181.
3. Allegrini P., Menicucci D., Bedini R., et al. Spontaneous brain activity as a source of ideal 1/f noise. Phys. Rev. E Stat. Nonlinear Soft Matter Phys. 2009, 80(6 Pt 1):18.
4. Alonso-Frech F., Zamarbide I., Alegre M., et al. Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease. Brain 2006, 129(Pt 7):1748-1757.
5. Androulidakis A.G., Doyle L.M., Yarrow K., Litvak V., Gilbertson T.P., Brown P. Anticipatory changes in beta synchrony in the human corticospinal system and associated improvements in task performance. Eur. J. Neurosci. 2007, 25(12):3758-3765.
6. Avila I., Parr-Brownlie L.C., Brazhnik E., Castaneda E., Bergstrom D.A., Walters J.R. Beta frequency synchronization in basal ganglia output during rest and walk in a hemiparkinsonian rat. Exp. Neurol. 2010, 221(2):307-319.
7. Ball T., Demandt E., Mutschler I., et al. Movement related activity in the high gamma range of the human EEG. NeuroImage 2008, 41(2):302-310.
8. Bergman H., Wichmann T., Karmon B., DeLong M.R. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J. Neurophysiol. 1994, 72(2):507-520.
9. Berke J.D. Fast oscillations in cortical-striatal networks switch frequency following rewarding events and stimulant drugs. Eur. J. Neurosci. 2009, 30(5):848-859.
10. Borgers C., Epstein S., Kopell N.J. Background gamma rhythmicity and attention in cortical local circuits: a computational study. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(19):7002-7007.
11. Brazhnik E., Cruz A.V., Avila I., et al. State-dependent spike and local field synchronization between motor cortex and substantia nigra in hemiparkinsonian rats. J. Neurosci. Off. J. Soc. Neurosci. 2012, 32(23):7869-7880.
12. Brazhnik E., Novikov N., McCoy A.J., Cruz A.V., Walters J.R. Functional correlates of exaggerated oscillatory activity in basal ganglia output in hemiparkinsonian rats. Exp. Neurol. 2014, 261:563-577.
13. Breger L.S., Dunnett S.B., Lane E.L. Comparison of rating scales used to evaluate L-DOPA-induced dyskinesia in the 6-OHDA lesioned rat. Neurobiol. Dis. 2013, 50:142-150.
14. Brittain J.S., Brown P. Oscillations and the basal ganglia: motor control and beyond. NeuroImage 2014, 2:637-647.
15. Brown P. Oscillatory nature of human basal ganglia activity: relationship to the pathophysiology of Parkinson's disease. Mov. Disord. 2003, 18(4):357-363.
16. Brown P., Oliviero A., Mazzone P., Insola A., Tonali P., Di Lazzaro V. Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson's disease. J. Neurosci. Off. J. Soc. Neurosci. 2001, 21(3):1033-1038.
17. Brucke C., Kempf F., Kupsch A., et al. Movement-related synchronization of gamma activity is lateralized in patients with dystonia. Eur. J. Neurosci. 2008, 27(9):2322-2329.
18. Brucke C., Bock A., Huebl J., et al. Thalamic gamma oscillations correlate with reaction time in a Go/noGo task in patients with essential tremor. NeuroImage 2013, 75:36-45.
19. Calon F., Rajput A.H., Hornykiewicz O., Bedard P.J., Di Paolo T. Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease. Neurobiol. Dis. 2003, 14:404-416.
20. Carta M., Lindgren H.S., Lundblad M., Stancampiano R., Fadda F., Cenci M.A. Role of striatal L-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats. J. Neurochem. 2006, 96(6):1718-1727.
21. Carta M., Carlsson T., Kirik D., Bjorklund A. Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats. Brain 2007, 130(Pt 7):1819-1833.
22. Cenci M.A. Dopamine dysregulation of movement control in L-DOPA-induced dyskinesia. Trends Neurosci. 2007, 30(5):236-243.
23. Cenci M.A., Lundblad M. Ratings of L-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice. Current Protocols in Neuroscience/Editorial Board, Jacqueline N Crawley [et al] 2007, (Chapter 9:Unit 9.25).
24. Cenci M.A., Ohlin K.E., Rylander D. Plastic effects of L-DOPA treatment in the basal ganglia and their relevance to the development of dyskinesia. Parkinsonism Relat. Disord. 2009, 1553:S59-S63.
25. Cheyne D., Ferrari P. MEG studies of motor cortex gamma oscillations: evidence for a gamma "fingerprint" in the brain?. Front. Hum. Neurosci. 2013, 7(575).
26. Cheyne D., Bells S., Ferrari P., Gaetz W., Bostan A.C. Self-paced movements induce high-frequency gamma oscillations in primary motor cortex. NeuroImage 2008, 42(1):332-342.
27. Chondrogiorgi M., Tatsioni A., Reichmann H., Konitsiotis S. Dopamine agonist monotherapy in Parkinson's disease and potential risk factors for dyskinesia: a meta-analysis of levodopa-controlled trials. Eur. J. Neurol. 2014, 21(3):433-440.
28. Darmopil S., Martin A.B., De Diego I.R., Ares S., Moratalla R. Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation. Biol. Psychiatry 2009, 66(6):603-613.
29. Degos B., Deniau J.M., Chavez M., Maurice N. Chronic but not acute dopaminergic transmission interruption promotes a progressive increase in cortical beta frequency synchronization: relationships to vigilance state and akinesia. Cereb. Cortex 2009, 19(7):1616-1630.
30. Delaville C., McCoy A.J., Gerber C.M., Cruz A.V., Walters J.R. Subthalamic nucleus activity in the awake hemiparkinsonian rat: relationships with motor and cognitive networks. J. Neurosci. Off. J. Soc. Neurosci. 2015, 35(17):6918-6930.
31. Devergnas A., Pittard D., Bliwise D., Wichmann T. Relationship between oscillatory activity in the cortico-basal ganglia network and parkinsonism in MPTP-treated monkeys. Neurobiol. Dis. 2014, 68:156-166.
32. Devos D., Szurhaj W., Reyns N., et al. Predominance of the contralateral movement-related activity in the subthalamo-cortical loop. Clin. Neurophysiol. 2006, 117(10):2315-2327.
33. Doyle L.M., Kuhn A.A., Hariz M., Kupsch A., Schneider G.H., Brown P. Levodopa-induced modulation of subthalamic beta oscillations during self-paced movements in patients with Parkinson's disease. Eur. J. Neurosci. 2005, 21(5):1403-1412.
34. Drake J.D., Kibuuka L.N., Dimitrov K.D., Pollack A.E. Abnormal involuntary movement (AIM) expression following D2 dopamine agonist challenge is determined by the nature of prior dopamine receptor stimulation (priming) in 6-hydroxydopamine lesioned rats. Pharmacol. Biochem. Behav. 2013, 105:26-33.
35. Dupre K.B., Eskow K.L., Negron G., Bishop C. The differential effects of 5-HT(1A) receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed hemiparkinsonian rat. Brain Res. 2007, 1158:135-143.
36. Dupre K.B., Ostock C.Y., Eskow Jaunarajs K.L., et al. Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats. Exp. Neurol. 2011, 229(2):288-299.
37. Dupre K.B., Ostock C.Y., George J.A., Eskow Jaunarajs K.L., Hueston C.M., Bishop C. Effects of 5-HT1A receptor stimulation on D1 receptor agonist-induced striatonigral activity and dyskinesia in hemiparkinsonian rats. ACS Chem. Neurosci. 2013, 4(5):747-760.
38. Eskow K.L., Dupre K.B., Barnum C.J., Dickinson S.O., Park J.Y., Bishop C. The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian rats. Synapse 2009, 63(7):610-620.
39. Fieblinger T., Sebastianutto I., Alcacer C., et al. Mechanisms of dopamine D1 receptor-mediated ERK1/2 activation in the parkinsonian striatum and their modulation by metabotropic glutamate receptor type 5. J. Neurosci. Off. J. Soc. Neurosci. 2014, 34(13):4728-4740.
40. Gatev P., Darbin O., Wichmann T. Oscillations in the basal ganglia under normal conditions and in movement disorders. Mov. Disord. 2006, 21(10):1566-1577.
41. Halje P., Tamte M., Richter U., Mohammed M., Cenci M.A., Petersson P. Levodopa-induced dyskinesia is strongly associated with resonant cortical oscillations. J. Neurosci. Off. J. Soc. Neurosci. 2012, 32(47):16541-16551.
42. Jankovic J. Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations. Mov. Disord. 2005, 20(Suppl. 11):S11-S16.
43. Jenkinson N., Kuhn A.A., Brown P. Gamma oscillations in the human basal ganglia. Exp. Neurol. 2013, 245:72-76.
44. Kempf F., Brucke C., Salih F., et al. Gamma activity and reactivity in human thalamic local field potentials. Eur. J. Neurosci. 2009, 29(5):943-953.
45. Kuhn A.A., Trottenberg T., Kivi A., Kupsch A., Schneider G.H., Brown P. The relationship between local field potential and neuronal discharge in the subthalamic nucleus of patients with Parkinson's disease. Exp. Neurol. 2005, 194(1):212-220.
46. Leblois A., Meissner W., Bioulac B., Gross C.E., Hansel D., Boraud T. Late emergence of synchronized oscillatory activity in the pallidum during progressive Parkinsonism. Eur. J. Neurosci. 2007, 26(6):1701-1713.
47. Lee S., Jones S.R. Distinguishing mechanisms of gamma frequency oscillations in human current source signals using a computational model of a laminar neocortical network. Front. Hum. Neurosci. 2013, 7:869.
48. Levy R., Ashby P., Hutchison W.D., Lang A.E., Lozano A.M., Dostrovsky J.O. Dependence of subthalamic nucleus oscillations on movement and dopamine in Parkinson's disease. Brain 2002, 125:1196-1209.
49. Lindenbach D., Dupre K.B., Eskow Jaunarajs K.L., Ostock C.Y., Goldenberg A.A., Bishop C. Effects of 5-HT1A receptor stimulation on striatal and cortical M1 pERK induction by L-DOPA and a D1 receptor agonist in a rat model of Parkinson's disease. Brain Res. 2013, 1537:327-339.
50. Litvak V., Eusebio A., Jha A., et al. Movement-related changes in local and long-range synchronization in Parkinson's disease revealed by simultaneous magnetoencephalography and intracranial recordings. J. Neurosci. Off. J. Soc. Neurosci. 2012, 32(31):10541-10553.
51. Lopez-Azcarate J., Tainta M., Rodriguez-Oroz M.C., et al. Coupling between beta and high-frequency activity in the human subthalamic nucleus may be a pathophysiological mechanism in Parkinson's disease. J. Neurosci. Off. J. Soc. Neurosci. 2010, 30(19):6667-6677.
52. Lundblad M., Andersson M., Winkler C., Kirik D., Wierup N., Cenci M.A. Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. Eur. J. Neurosci. 2002, 15(1):120-132.
53. Mallet N., Pogosyan A., Sharott A., et al. Disrupted dopamine transmission and the emergence of exaggerated beta oscillations in subthalamic nucleus and cerebral cortex. J. Neurosci. Off. J. Soc. Neurosci. 2008, 28(18):4795-4806.
54. Marceglia S., Foffani G., Bianchi A.M., et al. Dopamine-dependent non-linear correlation between subthalamic rhythms in Parkinson's disease. J. Physiol. 2006, 571(Pt 3):579-591.
55. Mela F., Marti M., Bido S., Cenci M.A., Morari M. In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels. Neurobiol. Dis. 2012, 45(1):573-582.
56. Muthukumaraswamy S.D. Functional properties of human primary motor cortex gamma oscillations. J. Neurophysiol. 2010, 104(5):2873-2885.
57. Olsson M., Nikkhah G., Bentlage C., Bjorklund A. Forelimb akinesia in the rat Parkinson model - differential-effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J. Neurosci. 1995, 15(5):3863-3875.
58. Ozkurt T.E., Butz M., Homburger M., et al. High frequency oscillations in the subthalamic nucleus: a neurophysiological marker of the motor state in Parkinson's disease. Exp. Neurol. 2011, 229(2):324-331.
59. Palva J.M., Zhigalov A., Hirvonen J., Korhonen O., Linkenkaer-Hansen K., Palva S. Neuronal long-range temporal correlations and avalanche dynamics are correlated with behavioral scaling laws. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(9):3585-3590.
60. Pelled G., Bergstrom D.A., Tierney P.L., et al. Ipsilateral cortical fMRI responses after peripheral nerve damage in rats reflect increased interneuron activity. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(33):14114-14119.
61. Pfurtscheller G., Graimann B., Huggins J.E., Levine S.P., Schuh L.A. Spatiotemporal patterns of beta desynchronization and gamma synchronization in corticographic data during self-paced movement. Clin. Neurophysiol. 2003, 114(7):1226-1236.
62. Priori A., Foffani G., Pesenti A., et al. Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson's disease. Exp. Neurol. 2004, 189(2):369-379.
63. Quiroga-Varela A., Walters J.R., Brazhnik E., Marin C., Obeso J.A. What basal ganglia changes underlie the parkinsonian state? The significance of neuronal oscillatory activity. Neurobiol. Dis. 2013, 58:242-248.
64. Rascol O., Brooks D.J., Korczyn A.D., De Deyn P.P., Clarke C.E., Lang A.E. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. N. Engl. J. Med. 2000, 342(20):1484-1491.
65. Rascol O., Nutt J.G., Blin O., Goetz C.G., Trugman J.M., Soubrouillard C., Carter J.H., Currie L.J., Fabre N., Thalamas C., Giardina W.J., Wright S. Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson's disease. Arch. Neurol. 2001, 58:249-254.
66. Ray N.J., Jenkinson N., Wang S., et al. Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation. Exp. Neurol. 2008, 213(1):108-113.
67. Raz A., Vaadia E., Bergman H. Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism. J. Neurosci. Off. J. Soc. Neurosci. 2000, 20(22):8559-8571.
68. Rivlin-Etzion M., Elias S., Heimer G., Bergman H. Computational physiology of the basal ganglia in Parkinson's disease. Prog. Brain Res. 2010, 183:259-273.
69. Robelet S., Melon C., Guillet B., Salin P., Kerkerian-Le G.L. Chronic L-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease. Eur. J. Neurosci. 2004, 20(5):1255-1266.
70. Sgambato-Faure V., Cenci M.A. Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease. Prog. Neurobiol. 2012, 96(1):69-86.
71. Sharott A., Magill P.J., Harnack D., Kupsch A., Meissner W., Brown P. Dopamine depletion increases the power and coherence of beta-oscillations in the cerebral cortex and subthalamic nucleus of the awake rat. Eur. J. Neurosci. 2005, 21(5):1413-1422.
72. Stathis P., Konitsiotis S., Antonini A. Dopamine agonists early monotherapy for the delay of development of levodopa-induced dyskinesias. Expert. Rev. Neurother. 2015, 15(2):207-213.
73. Syed E.C., Benazzouz A., Taillade M., et al. Oscillatory entrainment of subthalamic nucleus neurons and behavioural consequences in rodents and primates. Eur. J. Neurosci. 2012, 36(9):3246-3257.
74. Tan H., Pogosyan A., Anzak A., et al. Complementary roles of different oscillatory activities in the subthalamic nucleus in coding motor effort in Parkinsonism. Exp. Neurol. 2013, 248:187-195.
75. Trottenberg T., Fogelson N., Kuhn A.A., et al. Subthalamic gamma activity in patients with Parkinson's disease. Exp. Neurol. 2006, 200(1):56-65.
76. Weinberger M., Mahant N., Hutchison W.D., et al. Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease. J. Neurophysiol. 2006, 96(6):3248-3256.
77. Westin J.E., Vercammen L., Strome E.M., Konradi C., Cenci M.A. Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors. Biol. Psychiatry 2007, 62(7):800-810.
78. Whittington M.A., Traub R.D., Kopell N., Ermentrout B., Buhl E.H. Inhibition-based rhythms: experimental and mathematical observations on network dynamics. Int. J. Psychophysiol. 2000, 38:315-336.
79. Whittington M.A., Cunningham M.O., LeBeau F.E., Racca C., Traub R.D. Multiple origins of the cortical gamma rhythm. Dev. Neurobiol. 2011, 71(1):92-106.
80. Williams D., Tijssen M., van Bruggen G., Bosch A., Insola A., Di Lazzaro V., Mazzone P., Oliviero A., Quartarone A., Speelman H., Brown P. Dopamine-dependent changes in the functional connectivity between basal ganglia and cerebral cortex in humans. Brain 2002, 125:1558-1569.